NTHU Scientists Take a “Spin” onto the Next Generation MRAM
17.4.2019 19:30:00 EEST | Business Wire | Press release
Magnetoresistive random access memory (MRAM) is the forerunning candidate for the next generation digital technology. However, manipulating MRAM efficiently and effectively has been challenging. A revolutionary breakthrough was recently achieved by an interdisciplinary research team based at National Tsing Hua University (NTHU) in Taiwan, led by Prof. Chih-Huang Lai and Prof. Hsiu-Hau Lin. By adding a layer of platinum, only a few nanometers thick, it generates spin current to switch the pinned magnetic moments at will – a task that has never been accomplished before.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190417005048/en/
Professor Lai Chih-huang (left) and Lin Hsiu-hau of NTHU using hand gestures to represent the 0-1 concept in digital memory. (Photo: National Tsing Hua University)
From mobile phones to computers, wearable devices, the Internet of Things, and smart city operations, data processing and storage are essential. To allow faster reading and writing, less power consumption and retaining data through a power outage, MRAM stands out in the keen competitions. Lai and Lin’s breakthrough, published in Nature Materials recently, adds wings to MRAM technology and attracts attentions from both industry and academy.
Steering spin currents in MRAM
At present, information processing in digital devices is mainly carried out using dynamic random access memory (DRAM), but it consumes significant power and faces serious hurdles when reduced in size.
DRAM utilizes the charges of electrons. “But, electrons have both charge and spin.” Lai said, “Why can’t one work with electron spins to manipulate MRAM?” To put the idea into practice, Lai and Lin formed an interdisciplinary research team with doctoral students Bohong Lin and Boyuan Yang.
Lin explained that the structure of MRAM is like a sandwich. The upper layer consists of a freely flipping magnet, in charge of data computation, while the bottom layer consists of a fixed magnet, responsible for data storage; and these two layers are separated by an oxide layer.
The challenge is to switch these layers of different natures by electrical means. After a long series of experiments, they found the key ingredient: a nanometer layer of platinum. Due to spin-orbit interactions, the electric current drives the collective motion of electron spins first. The spin current then switches the pinned magnetic moment effectively and precisely.
Spintronics blazing hot
In recent years, NTHU has been promoting cross-disciplinary cooperation, such as the MRAM research conducted by the physicist Lin and the materials expert Lai, who have learned to work together seamlessly.
Major international companies all participate in the competition of MRAM development, including Samsung, Intel, and TSMC. It’s likely that mass production of high-density MRAM will begin sometime this year, a development where the research team led by Lai and Lin has played a key role.
The research team is currently extending their groundbreaking discovery to other structures, and their ongoing findings are expected to have major impacts on the development of memory industry. In Lai’s view, the development of MRAM technology is going to have a decisive influence on the future competitiveness of Taiwan's semiconductor industry.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190417005048/en/
Contact information
Media:
Holly Hsueh
Executive
Officer, Division of Public Affair
National Tsing Hua University
Tel:
(886)3-5162006
Mobile: (886)932-152535
Email: hoyu@mx.nthu.edu.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
